JNCE

Jounce Therapeutics, Inc.

Healthcare

Set alert

Price alert · JNCE

All alert types
1.88 0.00 0.00%
As of May 3, 2023
1.88 Day range 1.93

52-week range unavailable

Open
1.92
Prev close
1.88
Mkt cap
101.59M
Vol
11.60M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.88
High
1.93
Forward P/E
-1.83
Beta
0.75
Short ratio
0.48
Inst. own
85.33%
Dividend
0.00
Ex-div date
Earnings
May 4, 2023
50-d avg
1.64
200-d avg
1.93
1y target
2.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for JNCE has not been loaded yet. Try again in a moment.

Discussion (9)

Sign in to join the discussion

VICKY HANUKA JNCE 3 years ago #2

On May 2/23 JNCE will merge with REDX
You have to be in it to win it but buy buy

VICKY HANUKA JNCE 3 years ago #4

Jounce conducted a thorough review of both the proposed transaction with Concentra and the proposed Redx Business Combination, with the assistance of its legal and financial advisers, and Jounce's Board of Directors ultimately concluded that the proposed transaction with Concentra is in the best interest of Jounce stockholders, and therefore, unanimously approved the merger agreement with Concentra and withdrew its recommendation of the Redx Business Combination. On March 27, 2023, Jounce notified Redx of the withdrawal of its recommendation in favor of the Redx Business Combination and termination of the co-operation agreement dated February 23, 2023 between Jounce and Redx.

Given that Jounce's Board of Directors has withdrawn its recommendation to proceed with the Redx Business Combination, Jounce believes it is unlikely that Jounce stockholders would support the Redx Business Combination, which is a condition to closing the transaction. Accordingly, Jounce and Redx have agreed not to proceed with the proposed scheme of arrangement. In addition, Jounce has confirmed that it does not wish to switch to a contractual takeover offer. As a result, the U.K. Takeover Panel has confirmed that upon Redx announcing:

its withdrawal of its recommendation;
that it will not proceed with the scheme of arrangement; and
it has agreed to the release of Jounce from its obligation to proceed with the offer,

the offer period in respect of the Redx Business Combination will end with effect from the publication of Redx's announcement, and the transaction will lapse.

As a result, Jounce will not be convening a Jounce meeting of stockholders to consider the Redx Business Combination. Under the U.K. Takeover Code, except with consent of the U.K. Takeover Panel, Jounce must not, among other things, announce a further offer for Redx within 12 months from the date of this announcement.

VICKY HANUKA JNCE 3 years ago #5

Jounce conducted a thorough review of both the proposed transaction with Concentra and the proposed Redx Business Combination, with the assistance of its legal and financial advisers, and Jounce's Board of Directors ultimately concluded that the proposed transaction with Concentra is in the best interest of Jounce stockholders, and therefore, unanimously approved the merger agreement with Concentra and withdrew its recommendation of the Redx Business Combination. On March 27, 2023, Jounce notified Redx of the withdrawal of its recommendation in favor of the Redx Business Combination and termination of the co-operation agreement dated February 23, 2023 between Jounce and Redx.

Member JNCE 3 years ago #7

Is this gonna tank tomorrow when market goes red?

Oahupink JNCE 6 years ago #8

Keeping my shares overnight for sure